Aaron Gregory Schmidt, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hemagglutinin Glycoproteins, Influenza Virus | 12 | 2023 | 157 | 3.530 |
Why?
|
Antibodies, Viral | 32 | 2024 | 3177 | 2.450 |
Why?
|
Antibodies, Neutralizing | 27 | 2024 | 1978 | 2.360 |
Why?
|
Influenza Vaccines | 11 | 2023 | 738 | 2.250 |
Why?
|
Viral Envelope Proteins | 6 | 2022 | 636 | 1.640 |
Why?
|
Epitopes | 10 | 2022 | 2571 | 1.640 |
Why?
|
Virus Internalization | 7 | 2022 | 502 | 1.280 |
Why?
|
B-Lymphocytes | 11 | 2023 | 4666 | 1.210 |
Why?
|
Germinal Center | 4 | 2023 | 377 | 1.160 |
Why?
|
Dengue Virus | 4 | 2016 | 204 | 1.110 |
Why?
|
Immunity, Humoral | 10 | 2022 | 598 | 0.770 |
Why?
|
Coronavirus | 2 | 2021 | 158 | 0.710 |
Why?
|
Antibody Formation | 5 | 2024 | 1402 | 0.690 |
Why?
|
Influenza, Human | 5 | 2023 | 1479 | 0.680 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2019 | 90 | 0.660 |
Why?
|
Virion | 6 | 2022 | 433 | 0.550 |
Why?
|
Binding Sites, Antibody | 2 | 2015 | 349 | 0.550 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2016 | 459 | 0.510 |
Why?
|
Antigen Presentation | 1 | 2020 | 1284 | 0.480 |
Why?
|
Receptors, Virus | 2 | 2020 | 649 | 0.440 |
Why?
|
Orthomyxoviridae | 2 | 2016 | 156 | 0.420 |
Why?
|
Polysaccharides | 1 | 2019 | 1059 | 0.420 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2022 | 87 | 0.420 |
Why?
|
Antiviral Agents | 3 | 2016 | 2987 | 0.380 |
Why?
|
Aedes | 2 | 2014 | 100 | 0.380 |
Why?
|
Biomimetic Materials | 1 | 2012 | 179 | 0.370 |
Why?
|
Influenza A virus | 5 | 2020 | 456 | 0.340 |
Why?
|
Coronavirus Infections | 8 | 2020 | 3135 | 0.340 |
Why?
|
Pneumonia, Viral | 8 | 2020 | 3242 | 0.340 |
Why?
|
Cross Reactions | 5 | 2021 | 841 | 0.330 |
Why?
|
Peptides | 2 | 2012 | 4410 | 0.330 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2020 | 365 | 0.320 |
Why?
|
Immunoglobulin G | 10 | 2023 | 4561 | 0.320 |
Why?
|
Protein Engineering | 2 | 2021 | 538 | 0.310 |
Why?
|
Dengue | 1 | 2010 | 256 | 0.300 |
Why?
|
Glycosylation | 2 | 2021 | 1128 | 0.290 |
Why?
|
Models, Molecular | 3 | 2017 | 5451 | 0.290 |
Why?
|
Orthomyxoviridae Infections | 2 | 2019 | 248 | 0.280 |
Why?
|
HIV Antibodies | 3 | 2020 | 1322 | 0.280 |
Why?
|
Mice, Inbred BALB C | 5 | 2022 | 6387 | 0.270 |
Why?
|
HEK293 Cells | 6 | 2022 | 4208 | 0.270 |
Why?
|
Immunologic Memory | 5 | 2021 | 1348 | 0.270 |
Why?
|
Immunoglobulin M | 5 | 2020 | 1537 | 0.260 |
Why?
|
Antigens, Viral | 2 | 2021 | 1035 | 0.260 |
Why?
|
Animals | 29 | 2024 | 168770 | 0.260 |
Why?
|
Mice | 18 | 2024 | 81202 | 0.250 |
Why?
|
Macaca mulatta | 6 | 2021 | 2377 | 0.250 |
Why?
|
Viral Vaccines | 2 | 2020 | 636 | 0.250 |
Why?
|
Fetal Blood | 2 | 2021 | 1318 | 0.240 |
Why?
|
Nucleocapsid Proteins | 2 | 2023 | 77 | 0.240 |
Why?
|
Vaccines, Virus-Like Particle | 1 | 2024 | 40 | 0.230 |
Why?
|
Nasal Mucosa | 3 | 2020 | 373 | 0.220 |
Why?
|
Crystallography, X-Ray | 3 | 2019 | 2012 | 0.220 |
Why?
|
Immunoglobulin Variable Region | 2 | 2015 | 421 | 0.220 |
Why?
|
Immunoassay | 3 | 2021 | 752 | 0.220 |
Why?
|
Immunoglobulin A | 3 | 2020 | 995 | 0.220 |
Why?
|
Amino Acid Sequence | 8 | 2020 | 13814 | 0.210 |
Why?
|
Aluminum Hydroxide | 1 | 2022 | 58 | 0.210 |
Why?
|
Protein Binding | 6 | 2023 | 9384 | 0.210 |
Why?
|
Immunodominant Epitopes | 2 | 2021 | 267 | 0.200 |
Why?
|
Rotavirus | 1 | 2022 | 109 | 0.200 |
Why?
|
Vimentin | 1 | 2022 | 262 | 0.190 |
Why?
|
Vaccines, Attenuated | 1 | 2022 | 342 | 0.190 |
Why?
|
Receptors, Antigen, B-Cell | 3 | 2023 | 548 | 0.190 |
Why?
|
Receptors, IgG | 2 | 2021 | 582 | 0.190 |
Why?
|
Viral Load | 8 | 2021 | 3300 | 0.190 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 118 | 0.180 |
Why?
|
Pandemics | 10 | 2022 | 8386 | 0.180 |
Why?
|
Lymphocyte Activation | 2 | 2021 | 5524 | 0.180 |
Why?
|
Extracellular Space | 1 | 2022 | 595 | 0.180 |
Why?
|
Vaccination | 5 | 2023 | 3279 | 0.180 |
Why?
|
Antibodies | 3 | 2022 | 2460 | 0.170 |
Why?
|
Humans | 54 | 2024 | 744376 | 0.170 |
Why?
|
Immunoglobulin Fab Fragments | 3 | 2022 | 482 | 0.170 |
Why?
|
Heparitin Sulfate | 1 | 2020 | 225 | 0.170 |
Why?
|
Capsid Proteins | 1 | 2022 | 479 | 0.170 |
Why?
|
Vaccines, Synthetic | 4 | 2022 | 634 | 0.160 |
Why?
|
Molecular Sequence Data | 6 | 2015 | 18111 | 0.160 |
Why?
|
Enterocytes | 1 | 2020 | 225 | 0.160 |
Why?
|
Binding Sites | 5 | 2023 | 6111 | 0.160 |
Why?
|
Vaccines, DNA | 1 | 2020 | 305 | 0.160 |
Why?
|
Cricetinae | 3 | 2024 | 2475 | 0.160 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2020 | 314 | 0.160 |
Why?
|
Autoantigens | 2 | 2019 | 892 | 0.160 |
Why?
|
Peptide Fragments | 1 | 2010 | 5096 | 0.150 |
Why?
|
Molecular Dynamics Simulation | 3 | 2020 | 409 | 0.150 |
Why?
|
Goblet Cells | 1 | 2020 | 287 | 0.150 |
Why?
|
Immunization | 1 | 2021 | 1256 | 0.150 |
Why?
|
Cysteine | 1 | 2021 | 873 | 0.140 |
Why?
|
AIDS Vaccines | 1 | 2023 | 938 | 0.140 |
Why?
|
Immunization, Passive | 1 | 2019 | 623 | 0.140 |
Why?
|
Sialic Acids | 1 | 2016 | 128 | 0.140 |
Why?
|
Milk, Human | 1 | 2021 | 490 | 0.140 |
Why?
|
Respiratory Tract Infections | 1 | 2024 | 961 | 0.140 |
Why?
|
Interferon Type I | 1 | 2020 | 542 | 0.140 |
Why?
|
Adenoviridae | 1 | 2020 | 1101 | 0.140 |
Why?
|
Protein Conformation | 3 | 2022 | 4010 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2016 | 146 | 0.130 |
Why?
|
HIV Infections | 6 | 2023 | 16715 | 0.130 |
Why?
|
Vaccines | 1 | 2024 | 823 | 0.130 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2020 | 985 | 0.120 |
Why?
|
Complementarity Determining Regions | 1 | 2015 | 149 | 0.120 |
Why?
|
Recombinant Proteins | 2 | 2021 | 6621 | 0.120 |
Why?
|
West Nile virus | 1 | 2014 | 82 | 0.120 |
Why?
|
HIV-1 | 4 | 2020 | 6939 | 0.120 |
Why?
|
Molecular Mimicry | 1 | 2015 | 201 | 0.120 |
Why?
|
Bronchoalveolar Lavage Fluid | 3 | 2021 | 768 | 0.120 |
Why?
|
Cell Line | 7 | 2020 | 16000 | 0.120 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1320 | 0.110 |
Why?
|
Membrane Fusion | 1 | 2014 | 276 | 0.110 |
Why?
|
Mutation | 6 | 2021 | 29786 | 0.110 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2015 | 659 | 0.110 |
Why?
|
Point-of-Care Systems | 1 | 2020 | 1178 | 0.100 |
Why?
|
Placenta | 1 | 2020 | 1699 | 0.100 |
Why?
|
Seroepidemiologic Studies | 2 | 2023 | 402 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2019 | 2259 | 0.090 |
Why?
|
Serotyping | 1 | 2010 | 338 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2023 | 3873 | 0.090 |
Why?
|
Immunity, Cellular | 3 | 2020 | 1607 | 0.090 |
Why?
|
Survival Analysis | 2 | 2020 | 10252 | 0.090 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2014 | 952 | 0.090 |
Why?
|
Capsid | 2 | 2013 | 437 | 0.090 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2010 | 407 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2022 | 3486 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2026 | 0.080 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 21833 | 0.080 |
Why?
|
Peptide Library | 2 | 2021 | 349 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4386 | 0.080 |
Why?
|
Simian immunodeficiency virus | 1 | 2013 | 846 | 0.080 |
Why?
|
Female | 21 | 2022 | 380200 | 0.080 |
Why?
|
Protein Structure, Tertiary | 4 | 2016 | 3848 | 0.080 |
Why?
|
Hemagglutinins, Viral | 2 | 2018 | 67 | 0.070 |
Why?
|
Biological Evolution | 1 | 2013 | 1077 | 0.070 |
Why?
|
Cryoelectron Microscopy | 2 | 2022 | 576 | 0.070 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2019 | 2104 | 0.070 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2007 | 222 | 0.070 |
Why?
|
HLA-B Antigens | 1 | 2007 | 354 | 0.070 |
Why?
|
Antigens | 2 | 2022 | 1466 | 0.070 |
Why?
|
Virus Replication | 3 | 2021 | 2535 | 0.060 |
Why?
|
Serine Endopeptidases | 2 | 2020 | 1073 | 0.060 |
Why?
|
Male | 19 | 2022 | 350118 | 0.060 |
Why?
|
Pyrimidines | 1 | 2016 | 2943 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2018 | 9274 | 0.060 |
Why?
|
Evolution, Molecular | 1 | 2012 | 1939 | 0.060 |
Why?
|
Pan troglodytes | 1 | 2024 | 229 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2020 | 19233 | 0.060 |
Why?
|
Antibodies, Blocking | 1 | 2024 | 253 | 0.060 |
Why?
|
Serial Passage | 1 | 2022 | 23 | 0.050 |
Why?
|
Dogs | 2 | 2019 | 3912 | 0.050 |
Why?
|
Hemagglutinins | 1 | 2023 | 117 | 0.050 |
Why?
|
Protein Structure, Quaternary | 2 | 2014 | 436 | 0.050 |
Why?
|
HIV Antigens | 1 | 2023 | 347 | 0.050 |
Why?
|
Coronavirus OC43, Human | 1 | 2021 | 18 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2023 | 14723 | 0.050 |
Why?
|
Lung | 4 | 2021 | 9857 | 0.050 |
Why?
|
Phosphoproteins | 2 | 2020 | 2441 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2020 | 18034 | 0.050 |
Why?
|
Protein Structure, Secondary | 2 | 2014 | 1247 | 0.050 |
Why?
|
Haplorhini | 1 | 2021 | 552 | 0.050 |
Why?
|
Mesocricetus | 1 | 2020 | 252 | 0.050 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2007 | 1821 | 0.050 |
Why?
|
HL-60 Cells | 1 | 2020 | 365 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 193 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 291 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5535 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2021 | 915 | 0.040 |
Why?
|
Adult | 10 | 2022 | 214056 | 0.040 |
Why?
|
Antigen-Antibody Reactions | 1 | 2019 | 363 | 0.040 |
Why?
|
Lactation | 1 | 2021 | 412 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15535 | 0.040 |
Why?
|
Cohort Studies | 4 | 2022 | 40558 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2020 | 1095 | 0.040 |
Why?
|
Mutant Proteins | 1 | 2020 | 500 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2020 | 340 | 0.040 |
Why?
|
Middle Aged | 9 | 2021 | 213388 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2022 | 1341 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2021 | 541 | 0.040 |
Why?
|
Proteins | 1 | 2013 | 6100 | 0.040 |
Why?
|
Transgenes | 1 | 2021 | 1009 | 0.040 |
Why?
|
Interferometry | 1 | 2018 | 100 | 0.040 |
Why?
|
Massachusetts | 2 | 2020 | 8662 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2019 | 411 | 0.040 |
Why?
|
Kinetics | 2 | 2015 | 6476 | 0.040 |
Why?
|
Single-Chain Antibodies | 1 | 2017 | 108 | 0.040 |
Why?
|
Influenza in Birds | 1 | 2016 | 75 | 0.030 |
Why?
|
Dependovirus | 1 | 2021 | 706 | 0.030 |
Why?
|
Antibody Diversity | 1 | 2016 | 74 | 0.030 |
Why?
|
Cytokines | 2 | 2021 | 7323 | 0.030 |
Why?
|
Crystallization | 1 | 2016 | 525 | 0.030 |
Why?
|
Eggs | 1 | 2016 | 184 | 0.030 |
Why?
|
Antibody Affinity | 1 | 2016 | 254 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2020 | 1000 | 0.030 |
Why?
|
Chickens | 1 | 2016 | 865 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2016 | 677 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1837 | 0.030 |
Why?
|
Spleen | 1 | 2020 | 2362 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1677 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10183 | 0.030 |
Why?
|
Plasma Cells | 1 | 2016 | 591 | 0.030 |
Why?
|
Heparin | 1 | 2020 | 1637 | 0.030 |
Why?
|
Protein Stability | 1 | 2015 | 556 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3527 | 0.030 |
Why?
|
Models, Chemical | 1 | 2014 | 626 | 0.030 |
Why?
|
RNA, Viral | 1 | 2020 | 2901 | 0.030 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 808 | 0.030 |
Why?
|
Cats | 1 | 2013 | 1000 | 0.030 |
Why?
|
Molecular Structure | 1 | 2016 | 1899 | 0.020 |
Why?
|
Aged | 5 | 2022 | 163284 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1723 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1350 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 57776 | 0.020 |
Why?
|
Survivors | 1 | 2021 | 2291 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2023 | 9735 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4222 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6459 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2020 | 3424 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3130 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4479 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2021 | 2752 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 1877 | 0.020 |
Why?
|
Bacterial Toxins | 1 | 2016 | 931 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1678 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 56434 | 0.020 |
Why?
|
Antigens, Bacterial | 1 | 2016 | 1172 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2014 | 2556 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7294 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2183 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2014 | 971 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2022 | 4458 | 0.020 |
Why?
|
Mycobacterium tuberculosis | 1 | 2020 | 1832 | 0.020 |
Why?
|
Pregnancy | 2 | 2021 | 29144 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 4424 | 0.020 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2013 | 570 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8340 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 85784 | 0.020 |
Why?
|
Cyclophilin A | 1 | 2007 | 57 | 0.020 |
Why?
|
Tuberculosis | 1 | 2020 | 1912 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2018 | 5974 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12244 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3954 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 53291 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10388 | 0.020 |
Why?
|
Rats | 1 | 2022 | 24252 | 0.020 |
Why?
|
HIV | 1 | 2013 | 1604 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3596 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12025 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13285 | 0.020 |
Why?
|
Kidney | 1 | 2020 | 7184 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 1862 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21747 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2014 | 3690 | 0.010 |
Why?
|
Drug Resistance, Viral | 1 | 2007 | 820 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2013 | 4328 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6933 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25041 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7798 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6194 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 25628 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 63115 | 0.010 |
Why?
|
Child | 1 | 2020 | 77708 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 77459 | 0.010 |
Why?
|